Myocardium Assessment by Relaxation along Fictitious Field, Extracellular Volume, Feature Tracking, and Myocardial Strain in Hypertensive Patients with Left Ventricular Hypertrophy

Mirmojarabian, Seyed Amir; Lammentausta, Eveliina; Liukkonen, Esa; Ahvenjärvi, Lauri; Junttila, Juhani; Nieminen, Miika T.; Liimatainen, Timo

doi:https://doi.org/10.1155/2022/9198691

International Journal of Biomedical Imaging

On this page

Abstract Introduction Materials and Methods Results Discussion Conclusion Data Availability Conflicts of Interest Acknowledgments References Copyright Related Articles

Research Article | Open Access

Volume 2022 | Article ID 9198691 | https://doi.org/10.1155/2022/9198691

Myocardium Assessment by Relaxation along Fictitious Field, Extracellular Volume, Feature Tracking, and Myocardial Strain in Hypertensive Patients with Left Ventricular Hypertrophy

Seyed Amir Mirmojarabian,¹Eveliina Lammentausta,²Esa Liukkonen,²Lauri Ahvenjärvi,²Juhani Junttila,³Miika T. Nieminen,^1,2and Timo Liimatainen^1,2

Academic Editor: D. L. Wilson

Received10 Feb 2022

Accepted01 Jun 2022

Published23 Jun 2022

Abstract

Background. Previous research has shown impaired global longitudinal strain (GLS) and slightly elevated extracellular volume fraction (ECV) in hypertensive patients with left ventricular hypertrophy (HTN LVH). Up to now, only little attention has been paid to interactions between macromolecules and free water in hypertrophied myocardium. Purpose. To evaluate the feasibility of relaxation along a fictitious field with rank 2 (RAFF2) in HTN LVH patients. Study Type. Single institutional case control. Subjects. 9 HTN LVH (age, years) and 11 control subjects (age, years). Field Strength/Sequence. Relaxation time mapping (, , and with 11.8 μT maximum radio frequency field amplitude) was performed at 1.5 T using a Siemens Aera (Erlangen, Germany) scanner equipped with an 18-channel body array coil. Assessment. ECV was calculated using pre- and postcontrast , and global strains parameters were assessed by Segment CMR (Medviso AB Co, Sweden). The parametric maps of and were computed using a monoexponential model, while the Bloch-McConnell equations were solved numerically to model effect of the chemical exchange during radio frequency pulses. Statistical Tests. Parametric maps were averaged over myocardium for each subject to be used in statistical analysis. Kolmogorov-Smirnov was used as the normality test followed by Student’s t-test and Pearson’s correlation to determine the difference between the HTN LVH patients and controls along with Hedges’ effect size and the association between variables, respectively. Results. decreased statistically , and global longitudinal strain was impaired (GLS, ) in HTN LVH patients compared to the controls, respectively. Also, significant negative correlation was found between and GLS . Data Conclusion. Our results suggest that decrease in HTN LVH patients may be explained by gradual collagen accumulation which can be reflected in GLS changes. Most likely, it increases the water proton interactions and consequently decreases before myocardial scarring.

1. Introduction

Hypertension is a major public health concern and leading cause of morbidity and mortality globally. Based on international guidelines, hypertension is diagnosed as having and/or [1]. Systemic hypertension is known to increase the risk of developing left ventricular hypertrophy (LVH) and myocardial dysfunction through gene overexpression, protein synthesis, sarcomere rearrangement, and cell metabolism [1, 2]. The progression of LVH is an important determinant of sudden cardiac death and heart failure [2]. Based on left ventricular end-diastolic wall thickness, differential diagnosis between hypertensive LVH (HTN LVH) and hypertrophic cardiomyopathy (HCM) could be challenging [3–5]. Left ventricular global longitudinal strain (LV-GLS) derived from speckle tracking echocardiography (STE) is fast becoming a reliable and reproducible diagnostic tool in the evaluation of hypertrophied myocardium [6, 7]. A limitation of STE, however, is the suboptimal image quality due to insufficient echogenic windows, ultrasound dropouts, and reverberations [8].

Relaxation during radiofrequency pulse forms an endogenous magnetic resonance contrast which is commonly used to study low-frequency interactions between macromolecular content and free water in a wide range of organs and pathologies including musculoskeletal system [9, 10], cancer [11], and myocardial diseases [12, 13]. Many cohort studies have been published on spin-lattice relaxation in the rotating frame () characterizing irreversible myocardium injury. elevation has been found to be significant in the scar tissue at 4-8 weeks postinfarction in swine [14, 15]. Also, comparison of infarct size showed a satisfactory agreement between and late gadolinium enhancement (LGE) [12–16].

The concept of fictitious fields is originated from NMR experiments, where changes in the longitudinal magnetization are generated by a circularly polarized RF field in the xy plane. Based on fictitious field concept, relaxation along a fictitious field with rank (RAFFn) and relaxation time in presence of fictitious field () were developed to overcome the specific absorption rate (SAR) problem related to [17, 18]. In RAFFn, the fictitious field is formed by nested sinusoidal amplitude and cosine frequency-modulated RF pulses operating in subadiabatic regime. The presence of fictitious field increases the spin-locking field amplitude leading to reduced SAR, while probing low-molecular motions and generating MRI contrast [19–21]. Different rotating frames can be used to generate the fictitious field and its corresponding relaxation dispersion. The fictitious field rank is determined based on the rotating frame. For example, RAFF is called RAFF2, if the relaxation is occurring in the 2nd rotating frame. has been shown to accurately delineate myocardial infarct in a mouse model that is supported by significant correlation between tissue area with elevated and Sirius red-stained histology, and detected infarct sizes correlated highly with LGE in the mouse model [19]. A recent study of 18 patients with chronic myocardial infarction has shown that can be used to delineate focal myocardial fibrosis with clinically acceptable SAR-values [22]. In a previous study, the authors investigated progression of fibrosis in mice with induced hypertrophy using , , and and concluded that increases of and are most likely from expansion of extracellular volume, with contribution from increased fibrosis content and alterations in exchange rates [20].

The Bloch-McConnell equations are used for modeling the spatial-temporal behavior of the macroscopic magnetization in time-varying external magnetic fields. It is a suitable numerical tool to simulate chemical exchange for various applications including magnetization transfer (MT) or chemical exchange saturation transfer (CEST) imaging [23]. Given a water proton pool and a solute proton pool setup for Bloch-McConnell equations, it is possible to have a realistic simulation of proton chemical exchange in biological macromolecules.

Feature-tracking cardiac MRI (FT-CMR) is a tissue tracking technology for noninvasive assessment of myocardial deformation in research patients [8]. It employs offline tracking of the epi- and endocardial borders upon stacks of 2D cine images. The benefit of FT-CMR lies in quality of cine image and postprocessing operation. This eliminates extra image acquisition and time-consuming protocols which results in easier access and wider availability [24, 25]. There is a considerable amount of literature on prognostic value of FT-derived strain parameters in a wide range of cardiovascular disease such as nonischemic dilated cardiomyopathy, hypertensive heart disease, and hypertrophic cardiomyopathy. Global longitudinal strain (GLS) and global radial strain (GRS) derived from FT-CMR have been demonstrated to be impaired in HCM patients with preserved left ventricular ejection fraction (LVEF) [26]. Recent evidence also shows a significant correlation between global circumferential strain (GCS) and global extracellular volume fraction (ECV), in patients with nonischemic dilated cardiomyopathy [27], in HCM patients with positive and negative late gadolinium enhancement (LGE) [28], and more broadly in a heterogeneous patient population [29]. In addition, previous studies have investigated strain parameters for monitoring the damaged myocardium in HTN LVH patients [30–32].

What is known about hypertrophied myocardium is largely based on left ventricular wall thickness, presence of LGE enhancement, and LV dysfunction detected by impaired strain parameters. Several studies have found a mild increase in native and ECV in HTN LVH patients without increased LGE [33, 34]. Understanding the water molecular interaction with macromolecules will provide new insights into the progression of LVH in hypertensive patients. In this study, the focus is on myocardial hypertrophy characterization in HTN LVH patients using with comparisons to FT-derived strain parameters, native and ECV. Bloch-McConnell simulation was used to investigate contrast mechanisms.

2. Materials and Methods

2.1. Study Design and Study Population

The study was approved (159/2018) by the local ethics committee, and each participant provided written informed consent. Prospectively, 9 subjects with HTN LVH (mean age, years) and 11 normotensive controls (mean age, years) were enrolled between September 2019 and April 2020. All subjects were required to sign informed consent and be in desired physical condition to undergo MR imaging. The definition of HTN LVH was or on at least 2 office readings or taking one or more medications for hypertension followed by in at least one myocardial segment in LGE [33]. Exclusion criteria included significant coronary artery and valvular disease, interventions for septal reduction and pacemaker or defibrillator, other conditions that could cause LV wall thickness, renal impairment with glomerular filtration rate of <45 ml/min/1.73m², and moderate-to-severe systolic function ().

2.2. MRI Protocol and MRI Reporting

CMR were performed at 1.5 T using a Siemens Aera (Siemens Healthineers GmbH, Erlangen, Germany) scanner equipped with an 18-channel body array coil. Measurements were ECG-gated, and imaging was performed in breath-holds.

RAFF2 waveform was formed using sinusoidal pulse with initial 500 Hz amplitude [17, 18]. RAFF2 pulse trains were created by repeating the refocusing schemes with duration of 2.83 ms 0, 12, and 24 times. To synchronize RAFF2 measurements to the same cardiac phase, a variable delay was added between the -wave and the preparation block. In addition, a crusher gradient was employed to dephase the magnetization in xy plane prior to readout. The RAFF2 imaging parameters were as follows: 6 weighted images (3 with and 3 without an inversion pulse), balanced steady-state free precession (FISP) readout with repetition time (TR) one - interval, echo time (TE) 3.6 ms, matrix size , flip angle 20°, field of view (FOV) , and slice thickness 7 mm.

spin-locking pulse consisted of a hard excitation pulse, two halves of spin-lock pulse with reversed phases, and hard refocusing pulse between halves to correct the heterogeneity in the and transmit fields [35, 36]. After spin-lock, a hard excitation pulse returned magnetization back to the direction. Spin-locking times (TSL) were 0, 15, and 30 ms, and the preparation, refocusing, and return pulse amplitudes were 500 Hz. Based on spin-lock durations, a delay was applied to synchronize the readout to a specific time after ECG R-peak. data were fitted using a single monoexponential decay function [35, 36].

For quality control of spin-lock power, RF field amplitude was measured using a 1 ms hard pulse with varying power from 0 to 500 Hz. The measurement parameters were TR one cardiac cycle, , isotropic in-plane resolution 4.2 mm, flip angle 20°, slice thickness 7 mm, and FISP readout [37].

mapping was performed using a phase-sensitive variant of the modified Look-Locker inversion recovery (MOLLI) technique with balanced steady-state free precession (b-SSFP) readout. The imaging protocol consisted of a 5 s (3 s)3 s MOLLI sequence scheme with two sets of Look-Locker. This protocol yielded 5 weighted images over consecutive cardiac cycles during the first inversion recovery. Then, a three-heartbeat gap was followed by 3 weighted images over consecutive cardiac cycles during the second inversion recovery [38]. The native -mapping parameters were as follows: 8 weighted images, inversion time (TI) from 100 to 5000 ms, , isotropic in-plane resolution 1.2 mm, flip angle 35°, and slice thickness 7 mm. The postcontrast acquisition was performed at approximated 10 minutes after the intravenous injection of 0.3 ml/kg gadoteric acid (Grex Medical Oy, Finland) with following imaging parameters: 9 weighted images, , isotropic in-plane resolution 2.1 mm, flip angle 35°, and slice thickness 7 mm.

LGE images were captured using a 2D single inversion recovery prepared FISP sequence, 10 minutes after the intravenous injection. LGE images were visually evaluated for areas with elevated signal intensity following administration of contrast agent. The imaging parameters were , isotropic in-plane resolution 2.1 mm, flip angle 40°, and slice thickness 7 mm.

Multiplanar gated cine CMR was obtained using a standard balanced steady-state free precession readout. Short-axis and long-axis slices with coverage from cardiac base to apex were captured with the following parameters: number of frames 25, number of slices 13-15 depending on the size of heart, between single excitations, , isotropic in-plane resolution 2.1 mm, flip angle 55°, and slice thickness 8 mm.

Global strain analysis was performed using FT-CMR. Cine SSFP images in the short-axis and long-axis views were transferred into commercially available software (Segment CMR, Medviso AB Co, Sweden). Initially, the endocardial and epicardial borders of the myocardial tissue were drawn in each cine MRI image. The software, then, employed a tracking strategy based on nonrigid image registration to compute interframe deformation and consequently to estimate myocardial strain curves [24, 25]. Myocardial global circumferential strain (GCS) and global radial strain (GRS) were calculated from short-axis view and global longitudinal strain (GLS) was derived from long-axis view. To look at strain more locally, we calculated also segmental longitudinal strain shown in Figure 1(d). Peak, upslope rate (US rate) and downslope rate (DS rate) were calculated for strain curves (Figure 2). The myocardial mass and LVEF were also estimated by Segment CMR. LVED-WT was measured from LGE images using Aedes software package (http://aedes.uef.fi/).

2.3. Data Analysis

and maps were reconstructed using Aedes software (http://aedes.uef.fi/) in MATLAB R2017b platform (Mathworks Inc., Natick, Massachusetts, USA). RAFF2 weighted images were aligned prior to fitting procedure of RAFF2 map. The registration was performed to reduce misalignment artifacts in the final parameter fitting map using Matlab ver. R2017b Registration Estimator toolbox. Standard Siemens protocol was used for motion correction and relaxation time calculation [38]. Cycle frequency was fitted using single cosine function to obtain from data with varying preparation pulse duration. Native and postcontrast maps were aligned using the same registration function as RAFF2. ECV was calculated based on changes within native and postcontrast longitudinal relaxation rates () and the patient’s haematocrit (HCT from 0.37 to 0.47) value with following formula [39]:

Myocardia were delineated manually, as region of interest (ROI), using Aedes software from , , and ECV maps and LGE images by one observer. ROIs were traced with margins to stay safely inside the myocardium and avoid partial volume effect. Segment-wise analysis was performed for ECV and . Imaging data was acquired in mid-ventricular slice, and values therefore reported only respective AHA 17 model segments.

2.4. Statistical Analysis

Analysis was performed using SPSS software (version 17.0, SPSS, Inc., Chicago, IL, USA). Continuous data are presented as and categorical data as the number (%). The normality was confirmed by the Kolmogorov-Smirnov test. Student’s -test was used to compare the mean difference between the HTN LVH patients and controls in all variables. Also, the comparison was conducted in mid-layer segments for ECV and . Hedges’ effect size was calculated as the practical significance representing the standardized difference between means. Association between variables was assessed using Pearson correlation coefficients. An alpha level of 0.05 was used for all statistical tests.

2.5. Simulation

The value of was estimated using Bloch-McConnell equation in MATLAB (The Mathworks, USA) with a single monoexponential function for the decay of magnetization as described in [17, 18]. A two-pool model was used for proton exchange simulation between free water and hydroxyl group (-OH) representing myocardial collagen type I synthesis. The following parameters were used for OH protons: , [40], , , and .

3. Results

Bloch-McConnell simulations showed a constant exponential decay in , from 0.6 to 0.56, when increasing the -OH group concentration from 0.3 M to 0.5 M (Figure 3(c)). Compared to the controls, the HTN LVH patients were older () with a significantly reduced () and impaired global radial and longitudinal strains (GRS, ; GLS, ). A significant decrease was found in septal wall (segment 8 and 9) of HTN LVH patients using () (Figure 3(a)). Substantial difference between the HTN LVH patients and control group can be seen in myocardial strain rates (Table 1); however, GLS and GRS offered the highest practical significances among FT-derived strain parameters with , respectively. demonstrated a large practical significance () as observed for strain parameters. In addition, was correlated with LVED-WT, LVED mass, GLS (Table 2, Figure 4), and age (). The highest correlation was observed between and LVED mass ().

(a)

(b)

(c)

(a)

(b)

(c)

The HTN LVH patients displayed similar ECV and native values compared to the control group (ECV, ; , , respectively). Our analysis demonstrated a significant enlargement in LVED-WT, LVED mass (), and borderline LVEF () in HTN LVH patients. No noteworthy difference was observed between HTN LVH patients and controls in LGE images (Student’s -test ). was not correlated with and heart rate (). Altogether, these results show mildly impaired LV systolic function and hypertrophied myocardium with elevated ECV and in HTN LVH patients (Tables 1 and 2).

4. Discussion

In the current study, was used to characterize left ventricular hypertrophy in the absence of irreversible myocardial injury in hypertensive patients. The main findings were that decreased significantly in HTN LVH patients, was statistically associated with myocardium mass, thickness, and LV longitudinal shortening from the base to the apex, and despite significant growth in hypertrophied myocardium mass and thickness, subtle elevation was found in ECV and native (Table 1, Figure 1).

There are several examples of and used for imaging chronic scar tissue in the literature [12–20]. Elevated and were reported in fibrotic tissue of TAC-operated mice with mild and severe HCM [20]. Three possible reasons for this elevation were outlined: expansion of extracellular space caused by cell loss and progressive fibrosis, pH shifts, and macromolecular content alteration and proton molecular exchange. In their study, histological analysis was used to confirm fibrotic areas where and were elevated. In the current study, drew a statistically significant difference between HTN LVH patients and control group. Decreased in the hypertensive patient group compared to the control group agrees with the simulation, showing a major decrease in most likely by collagen deposition in HTN LVH patients. Furthermore, revealed a strong inverse association with myocardium mass, thickness, and GLS (Figure 4). The reason for this rather contradictory result is still not entirely clear, but collagen accumulation without significant increase in water mobility or water content is a reasonable explanation. Relatively low prolonged native and ECV provided evidence that there were no or only mild increase in extracellular water content. Therefore, it is very likely that increased collagen deposition leads to increased 1H molecular exchange and reduces myocardium .

Hemodynamic burden is a significant contributory factor to the development of LVH. The increase in LV mass and wall thickness occurs to compensate chronic pressure overload in hypertensive patients. However, it is the cellular and molecular response to sarcomere-gene mutations that induce collagen deposition and fibrotic remodeling [41]. Increased myocardial collagen synthesis leads to expansion of the extracellular space, and consequently, to development of left ventricular hypertrophy. Several studies have shown increased native and ECV in HTN LVH patients [33, 34]. Our findings are in line with previous results showing a relative increase in ECV () and native () of HTN LVH patients compared to controls. This result may be explained by the fact that fibrotic replacement is gradual as disease develops from collagen deposition to increased extracellular space.

Our results showed no correlation between and aging which confirms those of Wang et al. who also found that there is no association between and aging in myocardium [42]; however, we observed a significant decrease in with increasing subject’s age. Aging is a slow but life-long process associated with physiological changes in all organ systems. It increases arterial wall thickening and stiffness due to deposition of collagen and microscopic changes in cardiovascular systems [43]. Therefore, changes may partly be explained by the increased water proton interactions due to aging. The Bloch-MocConnell equations were used to simulate chemical exchange as the source of contrast mechanism in . Our results showed that there is a major difference between simulations (~600 ms) and measurements in vivo (~80 ms). The primary cause of the discrepancy is in numerous relaxation channels in vivo contributing to , while only proton exchange is resembled with Bloch-McConnell equations.

Several studies have shown impaired GLS in HTN LVH patients without LGE enhancement despite preserved LVEF [30–32]. GLS tracks myocardium deformation in long axis and disproportional LV thickening, while LVEF is a clinical measure of LV function. Neisius et al. reported significant correlation of GLS with LV mass index () and LVEF () in hypertensive patients [32]. In accordance with the research, our result confirms GLS impairment and its correlations with LV mass and LVEF. In addition, our findings showed higher practical significance for GLS and GRS compared to strain rates. This may mean that the limit of myocardial contraction at end-systole is more sensitive biomarker in differentiating HTN LVH compared to the rate of contraction at which deformations occur.

4.1. Limitations

The present study has some limitations. A small sample size and single center measurements were the most evident constraints. Also, the study was exploratory in nature with multiple measures being compared and correlated without correction for multiple comparisons leading to the increased risk of false positive findings. Prospective and diverse multicenter studies with the heterogeneous group of patient population are necessary to generalize our findings. Prognostic data are also needed to evaluate the prognostic value of the RAFF and FT-CMR strain in HTN LVH patients. Software packages are another limitation in our work. Since there is no standard protocol used in software packages, different registration framework or FT-CMR software package is possibly to introduce variability into our results. This might affect strain values or out-of-plane movement correction.

5. Conclusion

Our results demonstrate a good agreement between decreased and myocardial strain in the absence of scar tissue and mild diffuse fibrosis in hypertrophied myocardia. Most likely, augmented collagen content increases the water proton interactions which leads to a decrease in of hypertrophied tissue when extracellular space is still close to intact. Both theoretical simulation and empirical evidence support this hypothesis. can shed new light on early changes in myocardial pathology with preserved LVEF.

Data Availability

The MRI maps and extracted strains parameters used to support the findings of this study were approved by the local ethics committee and so cannot be made freely available. Requests for access to these data should be made to the corresponding author, Timo Liimatainen, [email protected].

Conflicts of Interest

The authors declare that they have no conflicts of interest.

Acknowledgments

The authors would like to thank Päivi Ronkainen for his/her helpful practical tips. The study is supported by the following organizations: Academy of Finland, Finnish Foundation for Cardiovascular Research, and Aarne Koskelo Foundation.

References

T. Unger, C. Borghi, F. Charchar et al., “2020 International Society of Hypertension Global Hypertension Practice Guidelines,” Hypertension, vol. 75, no. 6, pp. 1334–1357, 2020.
View at: Publisher Site | Google Scholar
M. H. Drazner, “The progression of hypertensive heart disease,” Circulation, vol. 123, no. 3, pp. 327–334, 2011.
View at: Publisher Site | Google Scholar
C. Méndez, R. Soler, E. Rodríguez, R. Barriales, J. P. Ochoa, and L. Monserrat, “Differential diagnosis of thickened myocardium: an illustrative MRI review,” Insights Into Imaging, vol. 9, no. 5, pp. 695–707, 2018.
View at: Publisher Site | Google Scholar
J. C. L. Rodrigues, A. M. Amadu, A. G. Dastidar et al., “Comprehensive characterisation of hypertensive heart disease left ventricular phenotypes,” Heart, vol. 102, no. 20, pp. 1671–1679, 2016.
View at: Publisher Site | Google Scholar
J. L. Zamorano, P. M. Elliott, A. Anastasakis et al., “ESC guidelines on diagnosis and management of hypertrophic cardiomyopathy: the task force for the diagnosis and management of hypertrophic cardiomyopathy of the European Society of Cardiology (ESC),” European Heart Journal, vol. 72, pp. 1054–1126, 2014.
View at: Google Scholar
T. C. P. Gil, M. B. Castier, A. F. P. Gondar et al., “Strain analysis of left ventricular function in the association of hypertrophic cardiomyopathy and systemic arterial hypertension,” Arquivos Brasileiros de Cardiologia, vol. 113, 2019.
View at: Publisher Site | Google Scholar
A. Tower-Rader, D. Mohananey, A. To, H. M. Lever, Z. B. Popovic, and M. Y. Desai, “Prognostic value of global longitudinal strain in hypertrophic cardiomyopathy: a systematic review of existing literature,” JACC: Cardiovascular Imaging, vol. 12, no. 10, pp. 1930–1942, 2019.
View at: Publisher Site | Google Scholar
P. Claus, A. M. S. Omar, G. Pedrizzetti, P. P. Sengupta, and E. Nagel, “Tissue tracking technology for assessing cardiac mechanics: principles, normal values, and clinical applications,” JACC: Cardiovascular Imaging, vol. 8, no. 12, pp. 1444–1460, 2015.
View at: Publisher Site | Google Scholar
A. W. Kajabi, V. Casula, M. J. Nissi et al., “Assessment of meniscus with adiabatic T_1ρ and T_2ρ relaxation time in asymptomatic subjects and patients with mild osteoarthritis: a feasibility study,” Osteoarthritis and Cartilage, vol. 26, no. 4, pp. 580–587, 2018.
View at: Publisher Site | Google Scholar
L. Wang and R. R. Regatte, “T₁ρ MRI of human musculoskeletal system,” Journal of Magnetic Resonance Imaging, vol. 41, no. 3, pp. 586–600, 2015.
View at: Publisher Site | Google Scholar
I. Jambor, M. Pesola, P. Taimen et al., “Rotating frame relaxation imaging of prostate cancer: repeatability, cancer detection, and Gleason score prediction,” Magnetic Resonance in Medicine, vol. 75, no. 1, pp. 337–344, 2016.
View at: Publisher Site | Google Scholar
Y. Han, T. Liimatainen, R. C. Gorman, and W. R. T. Witschey, “Assessing myocardial disease using T1ρ MRI,” Current Cardiovascular Imaging Reports, vol. 7, no. 2, p. 9248, 2014.
View at: Publisher Site | Google Scholar
H. S. N. Musthafa, G. Dragneva, L. Lottonen et al., “Longitudinal rotating frame relaxation time measurements in infarcted mouse myocardium in vivo,” Magnetic Resonance in Medicine, vol. 69, no. 5, pp. 1389–1395, 2013.
View at: Publisher Site | Google Scholar
W. R. Witschey, G. A. Zsido, K. Koomalsingh et al., “In vivo chronic myocardial infarction characterization by spin locked cardiovascular magnetic resonance,” Journal of Cardiovascular Magnetic Resonance, vol. 14, no. 1, 2012.
View at: Publisher Site | Google Scholar
J. W. M. van Oorschot and H. El Aidi, “endogenous assessment of chronic myocardial infarction with T1ρ-mapping in patients,” Journal of Cardiovascular Magnetic Resonance, vol. 16, no. 1, 2014.
View at: Publisher Site | Google Scholar
R. H. Stoffers, M. Madden, M. Shahid et al., “Assessment of myocardial injury after reperfused infarction by T1ρ cardiovascular magnetic resonance,” Journal of Cardiovascular Magnetic Resonance, vol. 19, no. 1, 2017.
View at: Publisher Site | Google Scholar
T. Liimatainen, H. Hakkarainen, S. Mangia et al., “MRI contrasts in high rank rotating frames,” Magnetic Resonance in Medicine, vol. 73, no. 1, pp. 254–262, 2015.
View at: Publisher Site | Google Scholar
T. Liimatainen, D. J. Sorce, R. O’Connell, M. Garwood, and S. Michaeli, “MRI contrast from relaxation along a fictitious field (RAFF),” Magnetic Resonance in Medicine, vol. 64, no. 4, pp. 983–994, 2010.
View at: Publisher Site | Google Scholar
E. Yla-Herttuala, S. Laidinen, H. Laakso, and T. Liimatainen, “Quantification of myocardial infarct area based on TRAFFn relaxation time maps - comparison with cardiovascular magnetic resonance late gadolinium enhancement, T1ρ and T2 in vivo,” Journal of Cardiovascular Magnetic Resonance, vol. 20, no. 1, p. 34, 2018.
View at: Publisher Site | Google Scholar
M. A. Khan, H. Laakso, S. Laidinen et al., “The follow-up of progressive hypertrophic cardiomyopathy using magnetic resonance rotating frame relaxation times,” NMR in Biomedicine, vol. 31, no. 2, article e3871, 2018.
View at: Publisher Site | Google Scholar
T. Liimatainen, A. Sierra, T. Hanson et al., “Glioma cell density in a rat gene therapy model gauged by water relaxation rate along a fictitious magnetic field,” Magnetic Resonance in Medicine, vol. 67, no. 1, pp. 269–277, 2012.
View at: Publisher Site | Google Scholar
S. A. Mirmojarabian, E. Liukkonen, V. Casula et al., “Relaxation along fictitious field (RAFF) provide an appropriate alternative method for imaging chronic myocardial infarct without exogenous contrast media,” Interventional Cardiology, vol. 13, p. 381, 2021.
View at: Google Scholar
C. Graf, A. Rund, C. S. Aigner, and R. Stollberger, “Accuracy and performance analysis for Bloch and Bloch-McConnell simulation methods,” Journal of Magnetic Resonance, vol. 329, article 107011, 2021.
View at: Publisher Site | Google Scholar
B. Heyde, R. Jasaityte, D. Barbosa et al., “Elastic image registration versus speckle tracking for 2-d myocardial motion estimation: a direct comparison in vivo,” IEEE Transactions on Medical Imaging, vol. 32, no. 2, pp. 449–459, 2013.
View at: Publisher Site | Google Scholar
P. Morais, A. Marchi, J. A. Bogaert et al., “Cardiovascular magnetic resonance myocardial feature tracking using a non-rigid, elastic image registration algorithm: assessment of variability in a real-life clinical setting,” Journal of Cardiovascular Magnetic Resonance, vol. 19, no. 1, p. 24, 2017.
View at: Publisher Site | Google Scholar
E. Cavus, K. Muellerleile, S. Schellert et al., “CMR feature tracking strain patterns and their association with circulating cardiac biomarkers in patients with hypertrophic cardiomyopathy,” Clinical Research in Cardiology, vol. 110, no. 11, pp. 1757–1769, 2021.
View at: Publisher Site | Google Scholar
M. Azuma, S. Kato, S. Kodama et al., “Relationship between the cardiac magnetic resonance derived extracellular volume fraction and feature tracking myocardial strain in patients with non- ischemic dilated cardiomyopathy,” Magnetic Resonance Imaging, vol. 74, pp. 14–20, 2020.
View at: Publisher Site | Google Scholar
L. M. Wu, D. A. L. An, Q. Y. Yao et al., “Hypertrophic cardiomyopathy and left ventricular hypertrophy in hypertensive heart disease with mildly reduced or preserved ejection fraction: insight from altered mechanics and native T1 mapping,” Clinical Radiology, vol. 72, no. 10, pp. 835–843, 2017.
View at: Publisher Site | Google Scholar
N. Rajpurohit, Z. Qian, S. Liu et al., “Global and regional extracellular volume and myocardial circumferential strain correlate significantly in a heterogeneous patient population,” Journal of Cardiovascular Magnetic Resonance, vol. 18, no. S1, 2016.
View at: Publisher Site | Google Scholar
J. Niu, M. Zeng, Y. Wang et al., “Sensitive marker for evaluation of hypertensive heart disease: extracellular volume and myocardial strain,” BMC Cardiovascular Disorders, vol. 20, no. 1, p. 292, 2020.
View at: Publisher Site | Google Scholar
H. Liu, J. Wang, Y. Pan, Y. Ge, Z. Guo, and S. Zhao, “Early and quantitative assessment of myocardial deformation in essential hypertension patients by using cardiovascular magnetic resonance feature tracking,” Scientific Reports, vol. 10, no. 1, 2020.
View at: Publisher Site | Google Scholar
U. Neisius, L. Myerson, A. S. Fahmy et al., “Cardiovascular magnetic resonance feature tracking strain analysis for discrimination between hypertensive heart disease and hypertrophic cardiomyopathy,” PLoS One, vol. 14, no. 8, article e0221061, 2019.
View at: Publisher Site | Google Scholar
S. Kuruvilla, R. Janardhanan, P. Antkowiak et al., “Increased extracellular volume and altered mechanics are associated with LVH in hypertensive heart disease, not hypertension alone,” JACC: Cardiovascular Imaging, vol. 8, no. 2, pp. 172–180, 2015.
View at: Publisher Site | Google Scholar
R. Y. Shi, R. Wu, D. A. L. An et al., “Texture analysis applied in T1 maps and extracellular volume obtained using cardiac MRI in the diagnosis of hypertrophic cardiomyopathy and hypertensive heart disease compared with normal controls,” Clinical Radiology, vol. 76, no. 3, pp. 236.e9–236.e19, 2021.
View at: Publisher Site | Google Scholar
W. R. T. Witschey, A. Borthakur, M. A. Elliott et al., “Compensation for spin-lock artifacts using an off-resonance rotary echo in T1rhooff-weighted imaging,” Magnetic Resonance in Medicine, vol. 57, no. 1, pp. 2–7, 2007.
View at: Publisher Site | Google Scholar
W. R. T. Witschey, J. J. Pilla, G. Ferrari et al., “Rotating frame spin lattice relaxation in a swine model of chronic, left ventricular myocardial infarction,” Magnetic Resonance in Medicine, vol. 64, no. 5, pp. 1453–1460, 2010.
View at: Publisher Site | Google Scholar
J. T. Vaughan, M. Garwood, C. M. Collins et al., “7T vs. 4T: RF power, homogeneity, and signal-to-noise comparison in head images,” Magnetic Resonance in Medicine, vol. 46, no. 1, pp. 24–30, 2001.
View at: Publisher Site | Google Scholar
H. Xue, A. Greiser, S. Zuehlsdorff et al., “Phase-sensitive inversion recovery for myocardial T1 mapping with motion correction and parametric fitting,” Magnetic Resonance in Medicine, vol. 69, no. 5, pp. 1408–1420, 2013.
View at: Publisher Site | Google Scholar
P. Haaf, P. Garg, D. R. Messroghli, D. A. Broadbent, J. P. Greenwood, and S. Plein, “Cardiac T1 mapping and extracellular volume (ECV) in clinical practice: a comprehensive review,” Journal of Cardiovascular Magnetic Resonance, vol. 18, no. 1, p. 89, 2016.
View at: Publisher Site | Google Scholar
W. Ling, R. R. Regatte, G. Navon, and A. Jerschow, “Assessment of glycosaminoglycan concentration in vivo by chemical exchange-dependent saturation transfer (gagCEST),” Proceedings of the National Academy of Sciences of the United States of America, vol. 105, no. 7, pp. 2266–2270, 2008.
View at: Publisher Site | Google Scholar
B. H. Lorell and B. A. Carabello, “Left ventricular hypertrophy,” Circulation, vol. 102, no. 4, pp. 470–479, 2000.
View at: Publisher Site | Google Scholar
L. Wang, J. Yuan, S.-J. Zhang et al., “MyocardialT1rho mapping of patients with end-stage renal disease and its comparison withT1mapping andT2mapping: a feasibility and reproducibility study,” Journal of Magnetic Resonance Imaging, vol. 44, no. 3, pp. 723–731, 2016.
View at: Publisher Site | Google Scholar
S. Saheera and P. Krishnamurthy, “Cardiovascular changes associated with hypertensive heart disease and aging,” Cell Transplantation, vol. 29, 2020.
View at: Publisher Site | Google Scholar

Copyright

Copyright © 2022 Seyed Amir Mirmojarabian et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

PDF Download Citation

Download other formats

Order printed copies

Views

917

Downloads

997

Citations